Human Cannabinoid Pharmacokinetics

Cited by (1,000)

Items 201–300 of 1,000

1. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users
   Dayong Lee, Mateus M. Bergamaschi, Garry Milman, Allan J. Barnes, Regina Helena Costa Queiróz, Ryan G. Vandrey, Marilyn A. Huestis · 2015 · Journal of Analytical Toxicology
2. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis
   Britta Hahn · 2017 · Schizophrenia Bulletin
3. Cerebellar alterations in cannabis users: A systematic review
   Chrysanthi Blithikioti, Laia Miquel, Albert Batalla, Belén Rubio Ballester, Giovanni Maffei, Ivan Herreros, Antoni Gual, Paul F. M. J. Verschure, Mercè Balcells‐Oliveró · 2019 · Addiction Biology
4. Human Cannabinoid Pharmacokinetics
   Marilyn Ann Huestis · 2007 · ChemInform
5. Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence
   Sam Craft, ADAM R. WINSTOCK, Jason Ferris, Clare J. Mackie, Michael T. Lynskey, Tom P. Freeman · 2019 · Psychological Medicine
6. Cannabinoid signalling and effects of cannabis on the male reproductive system
   Mauro Maccarrone, Cinzia Rapino, Felice Francavilla, Arcangelo Barbonetti · 2020 · Nature Reviews Urology
7. Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
   Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, Michael R. Boivin, Shaohua Lu · 2021 · Frontiers in Pharmacology
8. Effective treatment of spasticity using dronabinol in pediatric palliative care
   Michaela Kuhlen, Jessica I. Hoell, Gabriele Gagnon, Stefan Balzer, Prasad T. Oommen, Arndt Borkhardt, Gisela Janßen · 2016 · European Journal of Paediatric Neurology
9. Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users
   Yann Chye, Nadia Solowij, Chao Suo, Albert Batalla, Janna Cousijn, Anna E. Goudriaan, Rocío Martín‐Santos, Sarah Whittle, Valentina Lorenzetti, Murat Yücel · 2017 · Psychopharmacology
10. A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety
    Grant L. Steele, Tom J. Arneson, Dylan Michael Zylla · 2019 · Current Oncology Reports
11. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites
    Yuli Qian, Xinwen Wang, John Seth Markowitz · 2019 · Drug Metabolism and Disposition
12. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain
    Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, David A. Williams, Daniel Joseph Clauw · 2019 · Journal of Pain
13. Evaluation of pharmacokinetics and acute anti‐inflammatory potential of two oral cannabidiol preparations in healthy adults
    Jack M. Hobbs, Allegra R. Vazquez, Nicholas D. Remijan, Roxanne E. Trotter, Gear Thomas Vincent, Kimberly E. Freedman, Yuren Wei, Keith A. Woelfel, Olivia R. Arnold, Lisa M. Wolfe et al. · 2020 · Phytotherapy Research
14. Sex, Species and Age: Effects of Rodent Demographics on the Pharmacology of Δ9-Tetrahydrocanabinol
    J. Wiley, Daniel Barrus, C. Farquhar, T. Lefever, T. Gamage · 2020 · Progress in Neuro-psychopharmacology and Biological Psychiatry
15. Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms
    Justin Sinclair, Laura Collett, Jason Anthony Abbott, David W. Pate, Jerome J. Sarris, Mike Armour · 2021 · PLoS ONE
16. Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
    Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak‐Kim Chan, Philip Chi Lip Kwok · 2023 · Pharmaceutical Research
17. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
    Musa Basseer Sami, Sagnik Bhattacharyya · 2018 · Journal of Psychopharmacology
18. Cannflavins—From plant to patient: A scoping review
    Erridge, Simon, Mangal, Nagina, Salazar, Oliver, Pacchetti, Barbara, Sodergren, Mikael H. · 2020 · Fitoterapia
19. An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products
    Sarunya Kitdumrongthum, Dunyaporn Trachootham · 2023 · Molecules
20. Short and Divergent Total Synthesis of (+)‐Machaeriol B, (+)‐Machaeriol D, (+)‐Δ8‐THC, and Analogues
    Felix Klotter, Armido Studer · 2015 · Angewandte Chemie International Edition
21. Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization
    Katrina Mark, Mishka Terplan · 2017 · Preventive Medicine
22. Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction?
    Jennifer H. Martin, Jennifer Schneider, Catherine J. Lucas, Peter Galettis · 2017 · Clinical Pharmacokinetics
23. Medical cannabis for chronic pain: can it make a difference in pain management?
    Mari Kannan Maharajan, Yu Jing Yong, Hong Yang Yip, Sze Shee Woon, Kar Mon Yeap, Khai Yeng Yap, Shuen Chi Yip, Kai Xian Yap · 2019 · Journal of Anesthesia
24. Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
    Shivika Datta, Praveen Chandrashekarapura Ramamurthy, Uttpal Anand, Simranjeet Singh, Amritpal Singh, Daljeet Singh Dhanjal, Vaishali Dhaka, Sanjay Kumar, Dhriti Kapoor, Samapika Nandy et al. · 2021 · Saudi Journal of Biological Sciences
25. Cannabinol and Sleep: Separating Fact from Fiction
    Jamie Corroon · 2021 · Cannabis and Cannabinoid Research
26. Sensitive determination of THC and main metabolites in human plasma by means of microextraction in packed sorbent and gas chromatography–tandem mass spectrometry
    Tiago Rosado, L. Fernandes, Mário Barroso, Eugénia Gallardo · 2016 · Journal of Chromatography B
27. Postmortem Fluid and Tissue Concentrations of THC, 11-OH-THC and THC-COOH†
    Sunday Saenz, Russell J. Lewis, Mike K. Angier, Jarrad R. Wagner · 2017 · Journal of Analytical Toxicology
28. Perspectives on Cannabis as a Substitute for Opioid Analgesics
    Sara P. Khan, Thomas A. Pickens, Daniel J. Berlau · 2019 · Pain Management
29. The role of cannabis in treating anxiety
    Michael Van Ameringen, Jasmine Zhang, Beth A. Patterson, Jasmine Turna · 2019 · Current Opinion in Psychiatry
30. Enhancing Efficacy, Performance, and Reliability of Cannabis Edibles: Insights from Lipid Bioavailability Studies
    David Julian McClements · 2020 · Annual Review of Food Science and Technology
31. Cannabis for Pediatric Epilepsy
    Richard James Huntsman, Richard Tang‐Wai, Alan E. Shackelford · 2019 · Journal of Clinical Neurophysiology
32. Use of Medical Cannabis to Treat Traumatic Brain Injury
    Danielle C. Hergert, Cidney R. Robertson‐Benta, Veronik Sicard, Daniela Schwotzer, Kent E. Hutchison, Dan P. Covey, Davin K. Quinn, Joseph R. Sadek, Jacob D. McDonald, Andrew R. Mayer · 2020 · Journal of Neurotrauma
33. An Enhanced LC–MS-MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens
    Jami Reber, Erin L Karschner, Joshua Z Seither, Jessica L. Knittel, Katherine V Dozier, Jeffrey P. Walterscheid · 2022 · Journal of Analytical Toxicology
34. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
    Uri Bright, Irit Akirav · 2022 · International Journal of Molecular Sciences
35. Delta9‐tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature
    CJ Fowler · 2015 · Clinical Pharmacology & Therapeutics
36. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography–Tandem Mass Spectrometry
    David M. Andrenyak, David E. Moody, Matthew H. Slawson, Daniel S. OʼLeary, Margaret Haney · 2016 · Journal of Analytical Toxicology
37. Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a “tobacco substitute”
    Marianne Hädener, Tim J. Gelmi, Marie Martin Fabritius, Wolfgang Weinmann, Matthias Pfäffli · 2019 · International Journal of Legal Medicine
38. A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment
    Zuo Tong How, Mohamed Gamal El‐Din · 2020 · Environmental Pollution
39. Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
    Lauren Eadie, Lindsay A. Lo, April L. Christiansen, Jeffrey Reynold Brubacher, Alasdair M. Barr, William J. Panenka, Caroline A. MacCallum · 2021 · Frontiers in Psychiatry
40. Oral capsules of tetra‐hydro‐cannabinol ( THC ), cannabidiol ( CBD ) and their combination in peripheral neuropathic pain treatment
    Kanita Zubcevic, Merete Petersen, Flemming W. Bach, Aksel Heinesen, Thomas P. Enggaard, Thomas Almdal, Jakob Vormstrup Holbech, Lene Vase, Troels Stahelin Jensen, Christian Stevns Hansen et al. · 2022 · European Journal of Pain
41. Cannabis Pharmacogenomics: A Path to Personalized Medicine
    Mariana Babayeva, Zvi G. Loewy · 2023 · Current Issues in Molecular Biology
42. Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
    Uma Suryadevara, Dawn M. Bruijnzeel, Meena Nuthi, Darin A. Jagnarine, Rajiv Tandon, Adriaan W. Bruijnzeel · 2017 · Current Neuropharmacology
43. What the lab can and cannot do: clinical interpretation of drug testing results
    Bhushan M. Kapur, Katarina Aleksa · 2020 · Critical Reviews in Clinical Laboratory Sciences
44. Current legal status of medical marijuana and cannabidiol in the United States
    Yousef N. Alharbi · 2020 · Epilepsy & Behavior
45. Headspace solid-phase microextraction and gas chromatography−mass spectrometry for determination of cannabinoids in human breast milk
    Gabriela de Oliveira Silveira, Silvana Loddi, Carolina Dizioli Rodrigues de Oliveira, Alexandre Dias Zucoloto, Ligia Véras Gimenez Fruchtengarten, Maurı́cio Yonamine · 2016 · Forensic Toxicology
46. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
    Stephanie E. Reuter, Jennifer H. Martin · 2016 · Clinical Pharmacokinetics
47. Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safety
    Úrsula Escrivá, María Jesús Andrés-Costa, Vicente Andreu, Yolanda Picó · 2017 · Food Chemistry
48. A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single‐dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers
    Adele Hosseini, Andrew J. McLachlan, Jason D. Lickliter · 2020 · British Journal of Clinical Pharmacology
49. Postpartum Marijuana Use, Perceptions of Safety, and Breastfeeding Initiation and Duration: An Analysis of PRAMS Data From Seven States, 2017
    Kelsey C. Coy, Sarah C. Haight, Erica Hesch Anstey, Althea M. Grant, Nan M. Ruffo, Jean Y. Ko · 2021 · Journal of Human Lactation
50. Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start Study
    Brianna F. Moore, Kaytlyn Salmons, Adrienne T. Hoyt, Karli S. Swenson, Emily Anne Bates, Katherine Ann Sauder, Allison L. B. Shapiro, Greta N. Wilkening, Gregory L. Kinney, Andreas M. Neophytou et al. · 2023 · International Journal of Environmental Research and Public Health
51. Oral delivery of cannabidiol: Revealing the formulation and absorption challenges
    Andrejs Šitovs, Konstantīns Logviss, Līga Lauberte, Valentyn Mohylyuk · 2023 · Journal of Drug Delivery Science and Technology
52. Identification and quantification of psychoactive drugs in whole blood using dried blood spot (DBS) by ultra-performance liquid chromatography tandem mass spectrometry
    Chrystalla Kyriakou, Emilia Marchei, Giulia Scaravelli, Óscar García‐Algar, August Supervía, Silvia Graziano · 2016 · Journal of Pharmaceutical and Biomedical Analysis
53. Cannabinoid toxicity in pediatrics
    Eike Blohm, Peter Sell, Mark Neavyn · 2019 · Current Opinion in Pediatrics
54. Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol
    Constantin Itin, Dinorah Barasch, Abraham Jacob Domb, Amnon Hoffman · 2020 · International Journal of Pharmaceutics
55. Palmitoylethanolamide: A Potential Alternative to Cannabidiol
    Paul Clayton, Silma Subah, Ruchitha Venkatesh, Mariko Hill, Nathasha Omal Bogoda · 2021 · Journal of Dietary Supplements
56. Medical Marijuana in the Workplace
    Robert S. Goldsmith, Marcelo C. Targino, Gilbert J. Fanciullo, Douglas W. Martin, Natalie P. Hartenbaum, Jeremy M. White, Phillip J. Franklin · 2015 · Journal of Occupational and Environmental Medicine
57. Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
    Gabriela Pandini Silote, Michelle Carvalho Gatto, Amanda Eskelund, Francisco Silveira Guimarães, Gregers Wegener, Sâmia R.L. Joca · 2021 · Pharmaceuticals
58. Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
    Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, Kęstutis Petrikonis · 2023 · Pharmaceutics
59. Proof of cannabis administration by sensitive detection of 11‐nor‐Delta(9)‐tetrahydrocannabinol‐9‐carboxylic acid in hair using selective methylation and application of liquid chromatography‐ tandem and multistage mass spectrometry
    Detlef Thieme, Hans Sachs, Michaël Uhl · 2013 · Drug Testing and Analysis
60. Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study
    Lanfranco Pellesi, Manuela Licata, Patrizia Verri, Daniele Vandelli, Federica Palazzoli, Filippo Marchesi, Maria Michela Cainazzo, Luigi Alberto Pini, Simona Guérzoni · 2018 · European Journal of Clinical Pharmacology
61. A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
    Cathy Davies, Robin Paul Wilson, Elizabeth Appiah‐Kusi, Grace Blest‐Hopley, Michael John Brammer, Jesús Pérez, Robin M. Murray, Paul Allen, Matthijs Geert Bossong, Philip K. McGuire et al. · 2020 · Translational Psychiatry
62. Update on the developmental consequences of cannabis use during pregnancy and lactation
    Kimberly S. Grant, Elizabeth Ann Conover, Christina Chambers · 2020 · Birth Defects Research
63. Cannabidiol and Neurodevelopmental Disorders in Children
    Keith A. Kwan Cheung, Murray David Mitchell, Helen Heussler · 2021 · Frontiers in Psychiatry
64. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath
    Jacqueline A. Hubbard, Melissa A. Hoffman, Shannon Ellis, Philip M. Sobolesky, Breland E. Smith, Raymond T. Suhandynata, Emily G. Sones, Sandra Sanford, Anya Umlauf, Marilyn Ann Huestis et al. · 2021 · Journal of Analytical Toxicology
65. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
    Antistio Alviz-Amador, Neyder Contreras‐Puentes, Jairo Mercado‐Camargo · 2021 · Computational Biology and Chemistry
66. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
    Will Lawn, Katie Trinci, Claire Mokrysz, Anna Borissova, Shelan Ofori, Kat Petrilli, Michael Bloomfield, Zarah R. Haniff, Daniel Hall, Natalia Fernandez‐Vinson et al. · 2023 · Addiction
67. The endocannabinoid system — a target for the treatment of LUTS?
    Petter Hedlund, Christian Gratzke · 2016 · Nature Reviews Urology
68. Use of Marijuana Edibles by Adolescents in California
    Bettina Friese, Michael D. Slater, Robynn S. Battle · 2017 · The Journal of Primary Prevention
69. A novel single-step GC–MS/MS method for cannabinoids and 11-OH-THC metabolite analysis in hair
    Ilaria Angeli, Sara Casati, Alessandro Ravelli, Mauro Minoli, Marica Orioli · 2018 · Journal of Pharmaceutical and Biomedical Analysis
70. FABP1 controls hepatic transport and biotransformation of Δ9-THC
    Matthew W. Elmes, Lauren E. Prentis, Luke L. McGoldrick, Christopher J. Giuliano, Joseph Sweeney, Olivia M. Joseph, Joyce Che, Gregory Carbonetti, Keith M. Studholme, Dale G. Deutsch et al. · 2019 · Scientific Reports
71. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
    Jamie Corroon, Michelle Sexton, Ryan D. Bradley · 2019 · BMC Family Practice
72. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
    María Fernández-Trapero, Carmen Pérez-Díaz, Francisco Espejo‐Porras, Eva de Lago, Javier Fernández‐Ruíz · 2020 · Biomolecules
73. Maternal‐fetal transmission of delta‐9‐tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats
    Samantha L. Baglot, Jonathan W. VanRyzin, Ashley E. Marquardt, Robert J. Aukema, Gavin N. Petrie, Catherine Hume, Erin L. Reinl, John B. Bieber, Ryan J. McLaughlin, Margaret M. McCarthy et al. · 2021 · Journal of Neuroscience Research
74. Cannabis for Pain and Headaches: Primer
    Philip S. Kim, Michael Alan Fishman · 2017 · Current Pain and Headache Reports
75. Validated single urinary assay designed for exposomic multi-class biomarkers of common environmental exposures
    Ravikumar Jagani, Divya Pulivarthi, Dhavalkumar Patel, Rosalind J. Wright, Robert O. Wright, Manish Arora, Mary Snow Wolff, Syam S. Andra · 2022 · Analytical and Bioanalytical Chemistry
76. Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
    Guillermo Cásedas, Martín de Yarza-Sancho, Víctor López · 2024 · Pharmaceuticals
77. Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk
    Naveen Kumar Neradugomma, Kaitlyn Drafton, Gil Mor, Qingcheng Mao · 2019 · Reproductive Toxicology
78. Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence
    Karim Shiraz Ladha, Prabjit Ajrawat, Yi Yang, Hance A. Clarke · 2020 · Molecules
79. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
    Michelle Sexton, José M. Garcia, Aminah Jatoi, Carey S. Clark, Mark S. Wallace · 2021 · JNCI Monographs
80. Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies
    Carlos Austin Zamarripa, Ryan G. Vandrey, Tory R. Spindle · 2022 · Current Addiction Reports
81. Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions
    Arielle S. Gillman, Kent E. Hutchison, Angela D. Bryan · 2015 · Sports Medicine
82. Mucoadhesive tetrahydrocannabinol-loaded NLC – Formulation optimization and long-term physicochemical stability
    Ghaith Hommoss, Sung Min Pyo, Rainer Helmut Müller · 2017 · European Journal of Pharmaceutics and Biopharmaceutics
83. Marijuana in Orthopaedics: Effects on Bone Health, Wound-Healing, Surgical Complications, and Pain Management
    David M Heath, Ezekial J. Koslosky, Katherine C. Bartush, Grant Douglas Hogue · 2022 · JBJS Reviews
84. Antemortem and postmortem influences on drug concentrations and metabolite patterns in postmortem specimens
    Frank T. Peters, Andrea Eva Steuer · 2018 · Wiley Interdisciplinary Reviews Forensic Science
85. Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State
    Arum Kim, Christopher N. Kaufmann, Roxanne Ko, Zujun Li, Benjamin H. Han · 2019 · Journal of Palliative Medicine
86. Fast and Sensitive Quantification of Δ9-Tetrahydrocannabinol and Its Main Oxidative Metabolites by Liquid Chromatography/Tandem Mass Spectrometry
    Valentina Vozella, Cristina Zibardi, Faizy Ahmed, D. Piomelli · 2019 · Cannabis and Cannabinoid Research
87. The Protective Mechanism of Cannabidiol in Cardiac Injury: A Systematic Review of Non-Clinical Studies
    Mohammad Reza Hooshangi Shayesteh, Hamed Haghi‐Aminjan, Mohammad Javad Mousavi, Saeideh Momtaz, Mohammad Reza Abdollahi · 2019 · Current Pharmaceutical Design
88. DNA Methylation–Based Biomarkers of Environmental Exposures for Human Population Studies
    Jamaji C. Nwanaji‐Enwerem, Elena Colicino · 2020 · Current Environmental Health Reports
89. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder
    Michael D. Rizzo, Joseph E. Henriquez, Lance K. Blevins, Anthony P. Bach, Robert B. Crawford, Norbert E. Kaminski · 2020 · Journal of Neuroimmune Pharmacology
90. Cannabis vapor self-administration elicits sex- and dose-specific alterations in stress reactivity in rats
    Nicholas C. Glodosky, Carrie Cuttler, Timothy G. Freels, Hayden R. Wright, Manuel J. Rojas, Samantha L. Baglot, Matthew N. Hill, Ryan J. McLaughlin · 2020 · Neurobiology of Stress
91. Cannabinoids for skin diseases and hair regrowth
    Aditya Gupta, Mesbah Talukder · 2021 · Journal of Cosmetic Dermatology
92. Paternal Δ9-Tetrahydrocannabinol Exposure Prior to Mating Elicits Deficits in Cholinergic Synaptic Function in the Offspring
    Theodore A. Slotkin, Samantha Skavicus, Edward D. Levin, Frederic J. Seidler · 2020 · Toxicological Sciences
93. Cannabis extract nanoemulsions produced by high-intensity ultrasound: Formulation development and scale-up
    Shlomo Leibtag, Alexey S. Peshkovsky · 2020 · Journal of Drug Delivery Science and Technology
94. Influence of prenatal cannabinoid exposure on early development and beyond
    Megan K. Mulligan, Kristin M. Hamre · 2023 · Advances in Drug and Alcohol Research
95. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure
    Tallan Black, Sarah L. Baccetto, Ilne L. Barnard, Emma Finch, Dan L. McElroy, Faith V. L. Austin-Scott, Quentin Greba, Deborah L. Michel, Ayat Zagzoog, John G. Howland et al. · 2023 · Scientific Reports
96. The relationship between cannabis and cardiovascular disease: clearing the haze
    Mark Chandy, Nerea Jiménez-Téllez, Joseph C. Wu · 2025 · Nature Reviews Cardiology
97. High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis
    Casey J. Roulette, Mirdad Kazanji, Sébastien Breurec, Edward H. Hagen · 2015 · American Journal of Human Biology
98. Cannabis and anticancer drugs: societal usage and expected pharmacological interactions – a review
    Régis Bouquié, Guillaume Deslandes, Hélène Mazaré, Marion Cogné, Julien Mahé, Matthieu Grégoire, Pascale Jolliet · 2018 · Fundamental and Clinical Pharmacology
99. A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states
    Constantin Itin, Abraham Jacob Domb, Amnon Hoffman · 2019 · Expert Opinion on Drug Delivery
100. Adverse pharmacokinetic interactions between illicit substances and clinical drugs
     Kodye L. Abbott, Patrick C. Flannery, Kristina S. Gill, Dawn Merton Boothe, Muralikrishnan Dhanasekaran, Sridhar Mani, Satyanarayana R. Pondugula · 2019 · Drug Metabolism Reviews